| 1 |
35462605 | The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor. | 2022 Apr 25 |
1 |
| 2 |
34229060 | miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting. | 2021 Nov 1 |
1 |
| 3 |
31325888 | BDE-209 induces autophagy and apoptosis via IRE1α/Akt/mTOR signaling pathway in human umbilical vein endothelial cells. | 2019 Oct |
1 |
| 4 |
30514689 | [Combined treatment with myo-inositol and luteolin selectively suppresses growth of human lung cancer A549 cells possibly by suppressing activation of PDK1 and Akt]. | 2018 Nov 30 |
3 |
| 5 |
28119806 | Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy. | 2017 Jan |
1 |
| 6 |
28875849 | Modulation of both Insulin Resistance and Cancer Growth by Inositol. | 2017 |
1 |
| 7 |
29153661 | PKB/Akt and MAPK/ERK phosphorylation is highly induced by inositols: Novel potential insights in endothelial dysfunction in preeclampsia. | 2017 Oct |
8 |
| 8 |
27237097 | Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement. | 2016 Jul 1 |
1 |
| 9 |
27795708 | Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate. | 2016 |
1 |
| 10 |
19336734 | The chemopreventive agent myoinositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers. | 2009 Apr |
6 |
| 11 |
19689267 | Advances in development of phosphatidylinositol 3-kinase inhibitors. | 2009 |
1 |
| 12 |
18842113 | The life of a cell: apoptosis regulation by the PI3K/PKB pathway. | 2008 Nov 1 |
1 |
| 13 |
15087394 | Preferential inhibition of Akt and killing of Akt-dependent cancer cells by rationally designed phosphatidylinositol ether lipid analogues. | 2004 Apr 15 |
3 |